| 000 | 01278 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250511190826.0 | ||
| 264 | 0 | _c19921006 | |
| 008 | 199210s 0 0 eng d | ||
| 022 | _a0006-4971 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBiesma, B | |
| 245 | 0 | 0 |
_aEffects of interleukin-3 after chemotherapy for advanced ovarian cancer. _h[electronic resource] |
| 260 |
_bBlood _cSep 1992 |
||
| 300 |
_a1141-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterleukin-3 _xadverse effects |
| 650 | 0 | 4 |
_aLeukocyte Count _xdrug effects |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeutrophils _xdrug effects |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xblood |
| 650 | 0 | 4 |
_aPlatelet Count _xdrug effects |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadverse effects |
| 700 | 1 | _aWillemse, P H | |
| 700 | 1 | _aMulder, N H | |
| 700 | 1 | _aSleijfer, D T | |
| 700 | 1 | _aGietema, J A | |
| 700 | 1 | _aMull, R | |
| 700 | 1 | _aLimburg, P C | |
| 700 | 1 | _aBouma, J | |
| 700 | 1 | _aVellenga, E | |
| 700 | 1 | _ade Vries, E G | |
| 773 | 0 |
_tBlood _gvol. 80 _gno. 5 _gp. 1141-8 |
|
| 999 |
_c1522119 _d1522119 |
||